rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Tenax Therapeutics, Inc.

TENX · Nasdaq

Health CareBiotechnologyNot moving yet

TENX stood above a rising 150-day average in 37 of the last 52 weekly readings, and has been out of that trend for the last 11 weeks. It is 86.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 11
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$10.1M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
110 (+35)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 37 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$4.9MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months30
Sale orders, 12 months0
Buyers · sellers8 · 0
WhoDidSharesTraded
Declan DooganDirectorbought53,000at $1.9216 Sep 2026filed 17 Sep 2026
Christopher Thomas GiordanoCEObought4,850at $1.8215 Sep 2026filed 15 Sep 2026
Thomas R. Staab IIChief Financial Officerbought5,675at $1.9411 Sep 2026filed 15 Sep 2026
Christopher Thomas GiordanoCEObought6,000at $1.8811 Sep 2026filed 15 Sep 2026
Adar1 Capital Management, Llc10% ownerbought900,000at $1.783 Sep 2026filed 8 Sep 2026
Adar1 Capital Management, Llc10% ownerbought187,704at $1.802 Sep 2026filed 2 Sep 2026
Adar1 Capital Management, Llc10% ownerbought179,058at $1.801 Sep 2026filed 2 Sep 2026
Adar1 Capital Management, Llc10% ownerbought403,571at $1.7931 Aug 2026filed 2 Sep 2026
Adar1 Capital Management, Llc10% ownerbought107,374at $1.7524 Aug 2026filed 24 Aug 2026
Adar1 Capital Management, Llc10% ownerbought716,369at $1.7721 Aug 2026filed 24 Aug 2026
Adar1 Capital Management, Llc10% ownerbought202,124at $1.7820 Aug 2026filed 24 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders110+35 on the quarter
New · exited46 · 12
Reported value$433.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 20263,942,373$57.4M+3,619,773+1122.1%
Vivo Capital, LLCadded · filed 14 Aug 20262,500,000$36.4M+2,291,667+1100.0%
BlackRock, Inc.added · filed 7 Aug 20261,727,988$25.1M+1,711,011+10078.4%
PERCEPTIVE ADVISORS LLCadded · filed 14 Aug 20261,700,000$24.7M+252,218+17.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,147,121$16.7M+883,700+335.5%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026876,230$12.7M+342,341+64.1%
Ikarian Capital, LLCreduced · filed 14 Aug 2026787,600$11.5M-230,000−22.6%
Candriam S.C.A.new · filed 13 Aug 2026749,588$10.9M+749,588
CITADEL ADVISORS LLCadded · filed 14 Aug 2026728,561$10.6M+576,045+377.7%
RTW INVESTMENTS, LPadded · filed 14 Aug 2026696,570$10.1M+326,324+88.1%
31 Mar 2024 – 30 Jun 2026
17121225Mar 24Sep 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Declan Doogan Company insiderDirector · last 16 Sep 20261 · 0
Christopher Thomas Giordano Company insiderCEO · last 15 Sep 20265 · 0
Thomas R. Staab II Company insiderChief Financial Officer · last 11 Sep 20261 · 0
ADAR1 Capital Management, LLC Company insider10% owner · last 3 Sep 20267 · 0
Daniel Schneeberger Company insider10% owner · last 2 Sep 20266 · 0
Thomas McGauley Company insiderInterim CFO · last 30 Jan 20261 · 0
Gerald T. Proehl Company insiderDirector · last 9 Jan 20263 · 0
June Sherie Almenoff Company insiderDirector · last 9 Jan 20264 · 0
Michael H. Davidson Company insiderDirector · last 9 Jan 20261 · 0
Robyn Hunter Company insiderDirector · last 9 Jan 20260 · 0
Stuart Rich Company insiderChief Medical Officer · last 9 Jan 20265 · 0
Armistice Capital Master Fund Ltd. Company insiderDirector, 10% owner · last 18 May 20222 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-58.1%
Share count trendFY 2025 · to 6 Mar 202684.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$97.6M

Analyst forecasts

No analyst forecasts yet.